Compare SPR & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPR | ASH |
|---|---|---|
| Founded | 1927 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Specialty Chemicals |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 2.2B |
| IPO Year | 2006 | N/A |
| Metric | SPR | ASH |
|---|---|---|
| Price | $36.69 | $53.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $38.63 | ★ $60.14 |
| AVG Volume (30 Days) | ★ 1.3M | 896.9K |
| Earning Date | 10-31-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,393,600,000.00 | $1,824,000,000.00 |
| Revenue This Year | $21.51 | $3.18 |
| Revenue Next Year | $16.16 | $3.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.00 | $45.21 |
| 52 Week High | $42.33 | $80.66 |
| Indicator | SPR | ASH |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 60.93 |
| Support Level | $34.62 | $48.00 |
| Resistance Level | $36.06 | $51.19 |
| Average True Range (ATR) | 0.68 | 1.62 |
| MACD | 0.15 | 0.30 |
| Stochastic Oscillator | 96.27 | 93.83 |
Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005 to become the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue. The company plans to be acquired by and reintegrated into Boeing by the end of 2025.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.